Advanced metastatic prostate cancer can now be treated with precision therapy. Olaparib, a precision drug inhibits poly (ADP-ribose) polymerase (PARP) protein. Treating with Olaparib delays disease progression and time to pain progression, and prolongs survival of patients with advanced, metastatic prostate cancer.
Racial discrimination at an early age puts African Americans in a stressful environment which may lead to accelerated aging, premature development of serious health difficulties and a shorter life expectancy.
Meat-rich purchases can be reduced by between 40-80% by doubling the vegetarian options available on the menu without affecting overall food sales.
A new study published on Science Advances shows that it is possible to specifically conduct the fate of tissue cells by using visible light.
High schoolers are the unintended outcome of vaping devices and e-cigarettes even though it was targeted to adult smokers as a safer alternative.
